PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 153 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $633,840 | -39.6% | 38,000 | 0.0% | 0.54% | -31.5% |
| Q2 2023 | $1,049,560 | +119987.0% | 38,000 | 0.0% | 0.79% | +15.1% |
| Q1 2023 | $874 | +110.6% | 38,000 | 0.0% | 0.68% | +133.4% |
| Q4 2022 | $415 | -99.9% | 38,000 | 0.0% | 0.29% | +30.2% |
| Q3 2022 | $320,000 | +6.3% | 38,000 | 0.0% | 0.22% | +2.7% |
| Q2 2022 | $301,000 | -66.6% | 38,000 | 0.0% | 0.22% | -66.2% |
| Q1 2022 | $900,000 | -30.8% | 38,000 | 0.0% | 0.65% | -22.7% |
| Q4 2021 | $1,300,000 | +93.2% | 38,000 | 0.0% | 0.84% | +83.0% |
| Q3 2021 | $673,000 | +49.9% | 38,000 | +280.0% | 0.46% | +70.3% |
| Q2 2021 | $449,000 | +73.4% | 10,000 | 0.0% | 0.27% | +74.7% |
| Q1 2021 | $259,000 | – | 10,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |